Cargando…
25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype
CONTEXT: There is uncertainty over the equivalence of vitamins D(2) and D(3) to maintain plasma 25-hydroxyvitamin D (25(OH)D). OBJECTIVE: The objective of the study was to compare the plasma half-lives of 25(OH)D(2) and 25(OH)D(3) in two distinct populations with different dietary calcium intake and...
Autores principales: | Jones, K. S., Assar, S., Harnpanich, D., Bouillon, R., Lambrechts, D., Prentice, A., Schoenmakers, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207933/ https://www.ncbi.nlm.nih.gov/pubmed/24885631 http://dx.doi.org/10.1210/jc.2014-1714 |
Ejemplares similares
-
Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in The Gambia and the UK
por: Jones, K. S., et al.
Publicado: (2014) -
Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019) -
Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019) -
Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014) -
25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)(2)D(3)
por: Chiang, Kun-Chun, et al.
Publicado: (2016)